The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

ENANTA PHARMACEUTICALS INC insider acquisitions

Company CIK 0001177648 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
ENTA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Capps Kathleen S.Capps Kathleen S.Trout Harry R. IIITrout Harry R. IIILuu BrendanLuu BrendanKieffer Tara LynnKieffer Tara LynnKowalsky Matthew PaulKowalsky Matthew PaulRottinghaus Scott T.Rottinghaus Scott T.Or Yat SunOr Yat SunLuly Jay R.Luly Jay R.Capps Kathleen S. · November 25, 2025 · Stock award · Stock Option (right to buy)Capps Kathleen S. · November 25, 2025 · Stock award · Common StockTrout Harry R. III · November 25, 2025 · Stock award · Stock Option (right to buy)Trout Harry R. III · November 25, 2025 · Stock award · Common StockLuu Brendan · November 25, 2025 · Stock award · Stock Option (right to buy)Kieffer Tara Lynn · November 25, 2025 · Stock award · Stock Option (right to buy)Kowalsky Matthew Paul · November 25, 2025 · Stock award · Stock Option (right to buy)Rottinghaus Scott T. · November 25, 2025 · Stock award · Stock Option (right to buy)Or Yat Sun · November 25, 2025 · Stock award · Stock Option (right to buy)Luly Jay R. · November 25, 2025 · Stock award · Stock Option (right to buy)Nov 25, 2025Nov 25, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

10 dated transactions · 8 of 8 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Capps Kathleen S.Stock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCCommon StockCapps Kathleen S.Stock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Trout Harry R. IIIStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCCommon StockTrout Harry R. IIIStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Luu BrendanStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Kieffer Tara LynnStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Kowalsky Matthew PaulStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Rottinghaus Scott T.Stock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Or Yat SunStock award
Nov 25, 2025ENANTA PHARMACEUTICALS INCStock Option (right to buy)Luly Jay R.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

ENTA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardStock Option (right to buy)Derivative security · Code A6,3250Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A3,1630Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A12,9250Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A6,4630Value: 0Currency not specifiedView ↗
Trade:
Luu BrendanChief Business Officer
Stock awardStock Option (right to buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade:
Kieffer Tara LynnChief Product Strategy Officer
Stock awardStock Option (right to buy)Derivative security · Code A100,0000Value: 0Currency not specifiedView ↗
Trade:
Kowalsky Matthew PaulChief Legal Officer
Stock awardStock Option (right to buy)Derivative security · Code A90,0000Value: 0Currency not specifiedView ↗
Trade:
Rottinghaus Scott T.Chief Medical Officer
Stock awardStock Option (right to buy)Derivative security · Code A110,0000Value: 0Currency not specifiedView ↗
Trade:
Or Yat SunChief Scientific Officer
Stock awardStock Option (right to buy)Derivative security · Code A110,0000Value: 0Currency not specifiedView ↗
Trade:
Luly Jay R.President and CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A310,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →